Charanjit Aulakh

Array ( [id] => 8533571 [patent_doc_number] => 08309727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Opiate reduction utilizing catalytic hydrogen transfer reaction' [patent_app_type] => utility [patent_app_number] => 12/595519 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81808 [patent_doc_number] => 07745422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases' [patent_app_type] => utility [patent_app_number] => 12/103551 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13342 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745422.pdf [firstpage_image] =>[orig_patent_app_number] => 12103551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634706 [patent_doc_number] => 08013158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Crystalline forms of topotecan hydrochloride and processes for making the same' [patent_app_type] => utility [patent_app_number] => 12/082907 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 3903 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/013/08013158.pdf [firstpage_image] =>[orig_patent_app_number] => 12082907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792792 [patent_doc_number] => 20080293766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/101680 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11431 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293766.pdf [firstpage_image] =>[orig_patent_app_number] => 12101680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5455985 [patent_doc_number] => 20090256137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'N-TYPE SEMICONDUCTOR MATERIALS IN THIN FILM TRANSISTORS AND ELECTRONIC DEVICES' [patent_app_type] => utility [patent_app_number] => 12/101179 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13717 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20090256137.pdf [firstpage_image] =>[orig_patent_app_number] => 12101179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713335 [patent_doc_number] => 08399475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Crystalline and amorphous forms of naltrexone hydrochloride' [patent_app_type] => utility [patent_app_number] => 12/595543 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4934 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4600200 [patent_doc_number] => 07977483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Process for making topotecan' [patent_app_type] => utility [patent_app_number] => 12/082162 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1237 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977483.pdf [firstpage_image] =>[orig_patent_app_number] => 12082162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570531 [patent_doc_number] => 20090253910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Phosphorescent Materials' [patent_app_type] => utility [patent_app_number] => 12/098659 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 2004 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253910.pdf [firstpage_image] =>[orig_patent_app_number] => 12098659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493573 [patent_doc_number] => 20100209431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/596138 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18392 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209431.pdf [firstpage_image] =>[orig_patent_app_number] => 12596138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555531 [patent_doc_number] => 08067432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors' [patent_app_type] => utility [patent_app_number] => 12/058794 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5030 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067432.pdf [firstpage_image] =>[orig_patent_app_number] => 12058794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493628 [patent_doc_number] => 20100093697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/530676 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19281 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093697.pdf [firstpage_image] =>[orig_patent_app_number] => 12530676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059983 [patent_doc_number] => 08546418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Peripheral opioid receptor antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/593619 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10425 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283072 [patent_doc_number] => 08217175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Preparation of oxymorphone from oripavine' [patent_app_type] => utility [patent_app_number] => 12/532410 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5831 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12532410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995246 [patent_doc_number] => 08519131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Modified metal complex and use thereof' [patent_app_type] => utility [patent_app_number] => 12/530174 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 25065 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12530174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792781 [patent_doc_number] => 20080293755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'HETEROCYCLIC CYCLOPAMINE ANALOGS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/044817 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16406 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293755.pdf [firstpage_image] =>[orig_patent_app_number] => 12044817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995245 [patent_doc_number] => 08519130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Method for synthesis of iriduim (III) complexes with sterically demanding ligands' [patent_app_type] => utility [patent_app_number] => 12/044848 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22892 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12044848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446482 [patent_doc_number] => 08288535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Synthesis method of polymer complex crystal' [patent_app_type] => utility [patent_app_number] => 12/530240 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6154 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12530240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74417 [patent_doc_number] => 07750023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Quinuclidine derivatives and medicinal compositions containing the same' [patent_app_type] => utility [patent_app_number] => 12/074929 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27492 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750023.pdf [firstpage_image] =>[orig_patent_app_number] => 12074929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281968 [patent_doc_number] => 07553968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Synthesis of nicotine derivatives from nicotine' [patent_app_type] => utility [patent_app_number] => 12/043999 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5391 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553968.pdf [firstpage_image] =>[orig_patent_app_number] => 12043999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779422 [patent_doc_number] => 20080287420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'CYCLOPAMINE LACTAM ANALOGS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/044878 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17050 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287420.pdf [firstpage_image] =>[orig_patent_app_number] => 12044878 [rel_patent_id] =>[rel_patent_doc_number] =>)